振德医疗收盘下跌1.60%，滚动市盈率15.31倍，总市值55.58亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Zhendermedical, indicating a decline in net profit despite a slight increase in revenue [1][2] - Zhendermedical's closing stock price is 20.86 yuan, with a rolling PE ratio of 15.31 times, which is significantly lower than the industry average of 49.70 times [1][2] - The company has a total market capitalization of 5.558 billion yuan, ranking 36th in the medical device industry based on PE ratio [1][2] Group 2 - As of the first quarter of 2025, 15 institutions hold shares in Zhendermedical, with a total holding of 154.3014 million shares valued at 3.331 billion yuan [1] - The main business of Zhendermedical includes the research, production, and sales of medical and health products, with key products in basic care, surgical infection control, pressure treatment, and modern wound care [1] - The latest financial report shows that for the first quarter of 2025, the company achieved an operating income of 999.2 million yuan, a year-on-year increase of 2.87%, while net profit was 51.2419 million yuan, a year-on-year decrease of 30.19% [1]